Drug firm Alkem Laboratories on Friday reported more than two-fold jump in its consolidated net profit to Rs 423.19 crore for the quarter ended on June 30, 2020, mainly on account of robust sales in the US.
The company had posted a net profit of Rs 187.29 crore for the corresponding period of the previous fiscal, Alkem Laboratories said in a BSE filing.
Consolidated revenue from operations of the company stood at Rs 2,003.49 crore for the quarter under consideration. It was Rs 1,849.50 crore for the same period a year ago, it added.
"The company delivered a resilient performance

)